🇺🇸 FDA
Patent

US 6825213

&bgr;3-adrenoreceptor agonists, agonist compositions and methods of using

expired A61PA61P3/04A61P3/08

Quick answer

US patent 6825213 (&bgr;3-adrenoreceptor agonists, agonist compositions and methods of using) held by Molecular Design International, Inc. expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Molecular Design International, Inc.
Grant date
Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P3/04, A61P3/08, A61P3/10, A61P43/00